191 related articles for article (PubMed ID: 36573625)
1. Hormone replacement therapy in women with history of thrombosis or a thrombophilia.
Morris G; Talaulikar V
Post Reprod Health; 2023 Mar; 29(1):33-41. PubMed ID: 36573625
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone replacement therapy and venous thromboembolism.
Wu O
Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
[TBL] [Abstract][Full Text] [Related]
3. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
4. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.
Waselenko JK; Nace MC; Alving B
Semin Thromb Hemost; 1998; 24 Suppl 1():33-9. PubMed ID: 9840690
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and venous thromboembolism.
Eisenberger A; Westhoff C
J Steroid Biochem Mol Biol; 2014 Jul; 142():76-82. PubMed ID: 24007716
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
DeSancho MT; Dorff T; Rand JH
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy and venous thromboembolism].
Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
[TBL] [Abstract][Full Text] [Related]
9. Oral Contraceptives and HRT Risk of Thrombosis.
Gialeraki A; Valsami S; Pittaras T; Panayiotakopoulos G; Politou M
Clin Appl Thromb Hemost; 2018 Mar; 24(2):217-225. PubMed ID: 28049361
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
Cobin RH; Goodman NF;
Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
[TBL] [Abstract][Full Text] [Related]
12. Is the WHI relevant to HRT started in the perimenopause?
Harman SM; Brinton EA; Clarkson T; Heward CB; Hecht HS; Karas RH; Judelson DR; Naftolin F
Endocrine; 2004 Aug; 24(3):195-202. PubMed ID: 15542885
[TBL] [Abstract][Full Text] [Related]
13. The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy.
Bagot CN; Marsh MS; Whitehead M; Sherwood R; Roberts L; Patel RK; Arya R
J Thromb Haemost; 2010 Aug; 8(8):1736-44. PubMed ID: 20553380
[TBL] [Abstract][Full Text] [Related]
14. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
[TBL] [Abstract][Full Text] [Related]
15. The menopause and HRT. Hormone replacement therapy, cardiovascular and cerebrovascular disease.
Teede HJ
Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):73-90. PubMed ID: 12763513
[TBL] [Abstract][Full Text] [Related]
16. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Høibraaten E; Qvigstad E; Andersen TO; Mowinckel MC; Sandset PM
Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based indications for thrombophilia screening.
Lindhoff-Last E; Luxembourg B
Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
[TBL] [Abstract][Full Text] [Related]
18. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and menopause: a review of randomized, double-blind, placebo-controlled trials.
Chang C; Lin CH
Kaohsiung J Med Sci; 2003 Jun; 19(6):257-70. PubMed ID: 12873034
[TBL] [Abstract][Full Text] [Related]
20. The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue.
Ruan X; Mueck AO
Horm Mol Biol Clin Investig; 2018 Aug; 37(1):. PubMed ID: 30120909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
